Abstract Background Brain metastases (BM) occur in approximately 30–40% of lung cancer patients, with substantial morbidity. Management involves surgery, radiation therapy, and systemic treatments, but selecting appropriate therapy is challenging because aggressive interventions benefit some patients while exposing oth...
S. Chadha, D. Sritharan, Darin Dolezal et al.· Neuro-Oncology Advances· 0 citations
Abstract Artificial intelligence (AI) is increasingly being integrated into oncology for applications including cancer detection, risk stratification, treatment planning, and clinical documentation. Concerningly, growing evidence demonstrates that AI systems can reproduce or amplify existing disparities across patient...
Anand Srinivasan, D. Sritharan, S. Aneja et al.· JNCI Cancer Spectrum· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.